Non‐alcoholic fatty liver disease from pathogenesis to management: an update

Non‐alcoholic fatty liver disease from pathogenesis to management: an update

Summary Non‐alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the Western world, is tightly associated with obesity and metabolic syndrome. NAFLD entails an increased cardiometabolic and liver‐related risk, the latter regarding almost exclusively non‐alcoholic steatohep...

Fuld beskrivelse

Saved in:

Bibliografiske detaljer
Main Authors:	Giovanni Musso, Roberto Gambino, Maurizio Cassader
Format:	Revisão
Sprog:	engelsk
Udgivet:	2009
Online adgang:	https://doi.org/10.1111/j.1467-789x.2009.00657.x
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Lignende værker

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
af: Giovanni Musso, et al.
Udgivet: (2012)

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
af: Giovanni Musso, et al.
Udgivet: (2012)

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
af: Giovanni Musso, et al.
Udgivet: (2010)

PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease
af: Giovanni Musso, et al.
Udgivet: (2014)

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
af: Giovanni Musso, et al.
Udgivet: (2010)

Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
af: Giovanni Musso, et al.
Udgivet: (2013)

Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism
af: Giovanni Musso, et al.
Udgivet: (2013)

Association of obstructive sleep apnoea with the presence and severity of non‐alcoholic fatty liver disease. A systematic review and meta‐analysis
af: Giovanni Musso, et al.
Udgivet: (2013)

Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?
af: Giovanni Musso, et al.
Udgivet: (2008)

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities
af: Giovanni Musso, et al.
Udgivet: (2016)

Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver
af: Giovanni Musso, et al.
Udgivet: (2009)

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
af: Giovanni Musso, et al.
Udgivet: (2017)

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis
af: Musso, Giovanni, et al.
Udgivet: (2017)

Obesity, Diabetes, and Gut Microbiota: The hygiene hypothesis expanded?
af: Musso, Giovanni, et al.
Udgivet: (2010)

Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders
af: Giovanni Musso, et al.
Udgivet: (2010)

Obesity, Diabetes, and Gut Microbiota
af: Giovanni Musso, et al.
Udgivet: (2010)

Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH?
af: Roberto Gambino, et al.
Udgivet: (2007)

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
af: Elisabetta Bugianesi, et al.
Udgivet: (2005)

Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
af: Musso, Giovanni, et al.
Udgivet: (2013)

Sterol Regulatory Element-Binding Factor 2 (<i>SREBF-2</i>) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
af: Giovanni Musso, et al.
Udgivet: (2012)

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
af: Musso, Giovanni, et al.
Udgivet: (2019)

Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
af: Giovanni Musso, et al.
Udgivet: (2018)

A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
af: Giovanni Musso, et al.
Udgivet: (2011)

Diabetic ketoacidosis with SGLT2 inhibitors
af: Giovanni Musso, et al.
Udgivet: (2020)

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
af: Giovanni Musso, et al.
Udgivet: (2019)

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
af: Musso, Giovanni, et al.
Udgivet: (2020)

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
af: Giovanni Musso, et al.
Udgivet: (2020)

Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
af: Giovanni Musso, et al.
Udgivet: (2018)

Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
af: Giovanni Musso, et al.
Udgivet: (2012)

Transcription factor 7–like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH #
af: Giovanni Musso, et al.
Udgivet: (2008)

Pathogenesis and management issues for non-alcoholic fatty liver disease
af: Marko Duvnjak
Udgivet: (2007)

Pathogenesis of non-alcoholic fatty liver disease
af: J. K. Dowman, et al.
Udgivet: (2009)

Pathogenesis of non-alcoholic fatty liver disease
af: Dowman, J. K., et al.
Udgivet: (2010)

Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
af: Ullah, Rahim, et al.
Udgivet: (2019)

An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment.
af: Mouzaki, Marialena, et al.
Udgivet: (2020)

Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
af: Rahim Ullah, et al.
Udgivet: (2019)

Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH
af: Giovanni Musso, et al.
Udgivet: (2008)

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
af: Saira Rafaqat, et al.
Udgivet: (2024)

Non-alcoholic fatty liver disease: pathogenesis and models
af: Hanxiang Zhong
Udgivet: (2024)

Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease
af: Giovanni Musso, et al.
Udgivet: (2005)